Ignite Creation Date:
2024-05-06 @ 5:45 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05410197
Status:
RECRUITING
Last Update Posted:
2022-10-12
First Post:
2022-06-04
Brief Title:
Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line TreatmentENLIGHTEN
Sponsor:
Organization:
Sun Yat-sen University